Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Evesque, Ludovic
68  Ergebnisse:
Personensuche X
?
1

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology.  25 (2024)  4 - p. 518-528 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Chemoradiotherapy versus radiotherapy alone in the manageme..:

Buchalet, Chloé ; Lemanski, Claire ; Pommier, Pascal...
Digestive and Liver Disease.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ..:

Botsen, Damien ; Chabaud, Sylvie ; Perrier, Hervé...
Digestive and Liver Disease.  56 (2024)  8 - p. 1281-1287 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Durvalumab or placebo plus gemcitabine and cisplatin in par..:

Oh, Do-Youn ; He, Aiwu Ruth ; Bouattour, Mohamed...
The Lancet Gastroenterology & Hepatology.  9 (2024)  8 - p. 694-704 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Tislelizumab plus chemotherapy versus placebo plus chemothe..:

Qiu, Miao-Zhen ; Oh, Do-Youn ; Kato, Ken...
BMJ.  , 2024
Link: https://doi.org/10.1136/..
 
?
6

Pemigatinib for patients with previously treated, locally a..:

Parisi, Alessandro ; Delaunay, Blandine ; Pinterpe, Giada...
European Journal of Cancer.  200 (2024)  - p. 113587 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously..:

Kang, Yoon-Koo ; Ryu, Min-Hee ; Di Bartolomeo, Maria...
Gastric Cancer.  27 (2024)  2 - p. 375-386 , 2024
Link: https://doi.org/10.1007/..
 
?
8

Regorafenib plus FOLFIRINOX as first-line treatment for pat..:

Adenis, Antoine ; Ghiringhelli, François ; Gauthier, Ludovic...
Cancer Chemotherapy and Pharmacology.  , 2024
Link: https://doi.org/10.1007/..
 
?
9

Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ P..:

Evin, Cecile ; Quéro, Laurent ; Le Malicot, Karine...
International Journal of Radiation Oncology*Biology*Physics.  , 2024
Link: https://doi.org/10.1016/..
 
?
10

Prognostic impact of post-treatment FDG PET/CT in anal cana..:

Bailleux, Caroline ; Zwarthoed, Colette ; Evesque, Ludovic...
Radiotherapy and Oncology.  188 (2023)  - p. 109905 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Immunotherapy in MSI/dMMR tumors in the perioperative setti..:

Coutzac, Clélia ; Bibeau, Frederic ; Ben Abdelghani, Meher...
Digestive and Liver Disease.  54 (2022)  10 - p. 1335-1341 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Encorafenib plus cetuximab treatment in BRAF V600E-mutated ..:

Hafliger, Emilie ; Boccaccino, Alessandra ; Lapeyre-Prost, Alexandra...
European Journal of Cancer.  168 (2022)  - p. 34-40 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Failure of Initial Curative Treatment for Non-Metastatic An..:

Jaraudias, Claire ; Saint, Lucile Montagneb Angélique ; Schiappa, Renaud...
Clinical Colorectal Cancer.  21 (2022)  4 - p. 362-370 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mD..:

Kim, Stefano ; Boustani, Jihane ; Vernerey, Dewi...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
15

FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX..:

Adenis, Antoine ; Mazard, Thibault ; Fraisse, Julien...
BMC Cancer.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
1-15